Life SciencesCell BiologyOncologyCell DifferentiationHematologic OncologyMonoclonal AntibodiesAntibody CharacterizationCell Differentiation ControlHematopoietic DifferentiationLymphoid NeoplasmsTumor AntigensTumor DifferentiationAcute LeukemiasAcute Myeloid Leukemia BiologyLeukemia PathologyMonoclonal Antibodies In CancerMyeloid NeoplasmsSurface Topography Changes
The surface changes occurring in three acute myeloid leukemia cell lines (HL60, ML3, and KG1) induced to differentiate by a variety of agents (dimethylsulfoxide, retinoic acid, 12-O-tetradecanoylphorbol-13-acetate, and factors present in lymphocyte conditioned medium) were probed using monoclonal antibodies that are differentiation stage- and lineage-specific. In all cases, the differentiated phenotype was defective and varied with the inducing agent and the cell line used. HL60 proved to be the most sensitive to the effect of the inducers. Retinoic acid was better than DMSO, and TPA was better than the medium factors in the ability to induce granulocytic and monocytic differentiation, respectively, in HL60 cells. These findings indicate that the differentiation block in acute myeloid leukemias is heterogeneous and that each cell line has different phenotypic characteristics that are responsible for the extent of differentiation obtained with a given inducer. These results also suggest that the extent of the differentiation response in vitro may be improved by the use of more suitable inducers for each specific leukemic line.
15
Steven Collins, Francis W. Ruscetti, Robert E. Gallagher et al. · Proceedings of the National Academy of Sciences · 1978 · 1.6K citations · Full text
Medicine, Cell Biology, Hematology +14
Charlotte Friend, William Scher, J. G. Holland et al. · Proceedings of the National Academy of Sciences · 1971 · 1.4K citations · Full text
A monoclonal antibody reactive with human peripheral blood monocytes.
J Bréard, Ellis L. Reinherz, Patrick C. Kung et al. · The Journal of Immunology · 1980 · 833 citations · Full text